Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Share Capital	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Balance at Dec. 31, 2017	$ 316,369	$ 12	$ 771,813	$ (35,111)	$ (420,345)
Balance (Shares) at Dec. 31, 2017		122,634,922
Adoption of new accounting standards	3,776			(986)	4,762
Issuance of shares for acquisition	20,144		20,144
Issuance of shares for acquisition (in shares)		1,735,269
Vesting of RSU's (in shares)		375
Equity-based compensation expense	1,341		1,341
Net income (loss)	(442)				(442)
Foreign currency translation adjustments	7,075			7,075
Balance at Mar. 31, 2018	348,263	$ 12	793,298	(29,022)	(416,025)
Balance (Shares) at Mar. 31, 2018		124,370,566
Balance at Dec. 31, 2017	$ 316,369	$ 12	771,813	(35,111)	(420,345)
Balance (Shares) at Dec. 31, 2017		122,634,922
Exercise of stock options (in shares)	0
Net income (loss)	$ (13,209)
Foreign currency translation adjustments	(20,796)
Balance at Sep. 30, 2018	309,996	$ 13	795,668	(56,893)	(428,792)
Balance (Shares) at Sep. 30, 2018		132,713,555
Balance at Mar. 31, 2018	348,263	$ 12	793,298	(29,022)	(416,025)
Balance (Shares) at Mar. 31, 2018		124,370,566
Conversion of warrants to common stock		$ 1	(1)
Conversion of warrants to common stock (in shares)		6,342,989
Equity-based compensation expense	868		868
Net income (loss)	(6,583)				(6,583)
Foreign currency translation adjustments	(25,392)			(25,392)
Balance at Jun. 30, 2018	317,156	$ 13	794,165	(54,414)	(422,608)
Balance (Shares) at Jun. 30, 2018		130,713,555
Issuance of earn-out shares (in shares)		2,000,000
Equity-based compensation expense	1,503		1,503
Net income (loss)	(6,184)				(6,184)
Foreign currency translation adjustments	(2,479)			(2,479)
Balance at Sep. 30, 2018	309,996	$ 13	795,668	(56,893)	(428,792)
Balance (Shares) at Sep. 30, 2018		132,713,555
Balance at Dec. 31, 2018	288,317	$ 13	797,222	(68,941)	(439,977)
Balance (Shares) at Dec. 31, 2018		132,716,541
Issuance of shares for acquisition	182,248	$ 2	182,246
Issuance of shares for acquisition (in shares)		15,591,186
Vesting of RSU's (in shares)		375
Exercise of stock options	264		264
Exercise of stock options (in shares)		20,625
Equity-based compensation expense	2,081		2,081
Net income (loss)	11,634				11,634
Foreign currency translation adjustments	6,851			6,851
Balance at Mar. 31, 2019	491,395	$ 15	981,813	(62,090)	(428,343)
Balance (Shares) at Mar. 31, 2019		148,328,727
Balance at Dec. 31, 2018	$ 288,317	$ 13	797,222	(68,941)	(439,977)
Balance (Shares) at Dec. 31, 2018		132,716,541
Exercise of stock options (in shares)	43,125
Net income (loss)	$ 6,241
Foreign currency translation adjustments	(6,263)
Balance at Sep. 30, 2019	479,439	$ 15	988,364	(75,204)	(433,736)
Balance (Shares) at Sep. 30, 2019		148,478,535
Balance at Mar. 31, 2019	491,395	$ 15	981,813	(62,090)	(428,343)
Balance (Shares) at Mar. 31, 2019		148,328,727
Exercise of stock options	288		288
Exercise of stock options (in shares)		22,500
Equity-based compensation expense	2,562		2,562
Net income (loss)	(7,758)				(7,758)
Foreign currency translation adjustments	(945)			(945)
Balance at Jun. 30, 2019	$ 485,542	$ 15	$ 984,663	(63,035)	(436,101)
Balance (Shares) at Jun. 30, 2019		148,351,227
Vesting of RSU's (in shares)	(121)	81,960	(121)
Issuance of shares from ESPP	$ 315		$ 315
Issuance of shares from ESPP (in shares)		45,348
Equity-based compensation expense	3,507		3,507
Net income (loss)	2,365				2,365
Foreign currency translation adjustments	(12,169)			(12,169)
Balance at Sep. 30, 2019	$ 479,439	$ 15	$ 988,364	$ (75,204)	$ (433,736)
Balance (Shares) at Sep. 30, 2019		148,478,535

CISION LTD. 10-Q